JPRN-UMIN000045947尚未招募未知
Prospective comparison of mirabegron and fesoterodine for overactive bladder - Prospective comparison of mirabegron and fesoterodine for overactive bladder
agasaki University Hospital Department of urology0 个研究点目标入组 140 人开始时间: 2021年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded if they received treatment with anticholinergic agents,beta3-adrenoceptor agonist,BOTOX injection,propafenone hydrochloride or flecainide acetate; if they had hypersensitivity to mirabegron,fesoterodine or tolterodine; if they had renal dysfunction,hepatic dysfunction,severe cardiac disease,urinary retention,closed-angle glaucoma,ileus,atony or myasthenia gravis; if they are not able to answer questionnaires and they need proxies; if they are pregnant or want to have a baby in the future; and if they pacitipated other clinical research.
研究者
相似试验
尚未招募
4 期
A comparison of medicines used for overactive bladder (fesoterodine vs mirabegron vs solifenacin)CTRI/2024/02/063069VYOMA DESAI
未知
4 期
Comparison of fesoterodine and mirabegron in the treatment of female overactive baldder patients with urgency incontinence: A randomized, prospective study (Feminine study)overactive bladderJPRN-UMIN000024442Department of urology, Nagoya University Graduate School of Medicine300
尚未招募
4 期
Comparing the efficacy of Mirabegron in reducing urinary symptoms associated with cerebrovascular accidentsCTRI/2023/03/050511DEPARTMENT OF UROLOGY KASTURBA MEDICAL COLLEGE MANIPA
尚未招募
4 期
Comparing the efficacy of Mirabegron in reducing urinary symptoms associated with Parkinsons diseaseCTRI/2023/01/048770DEPARTMENT OF UROLOGY KASTURBA MEDICAL COLLEGE MANIPA
招募中
4 期
Comparison of vibegron and mirabegron in the treatment of female over active bladder subjects: A randomized, prospective studyoveractive bladderJPRN-UMIN000038288Department of urology, Hokusuikai Kinen Hospital100